Prevalence and Variation of CHIP in Patients with Aggressive Lymphomas Undergoing CD19-Directed CAR-T Cell Treatment

By
Justin.choi
-
0
153
The authors defined the prevalence and variation of clonal hematopoiesis of indetermined potential (CHIP) over time and assessed the influence on clinical inflammation syndromes, cytopenia and outcome.
[Blood Advances]

Sorry, but the selected Zotpress account can't be found.

Abstract